Kai Wucherpfennig MD PhD is Professor and Chair of the Department of Cancer Immunology and Virology at the Dana-Farber Cancer Institute and Professor of Neurology at Harvard Medical School.
Prof. Wucherpfennig’s research focuses on the discovery of genes that control the activity of cytotoxic T cells in the tumor microenvironment drawing insights for the development of next-generation cancer immunotherapies. He has received a number of honors and awards, including his election as a Fellow in the American Society for the Advancement of Science, his election as a member of the Henry Kunkel Society at Rockefeller University, and his election as a member of the American Society for Clinical Investigation. He received his MD and PhD degrees from the University of Goettingen and completed post-doctoral work in immunology at Brigham & Women’s Hospital, Harvard Medical School, and Harvard College. Wucherpfennig serves as an advisor to a number of immuno-oncology companies and since 2015 is an exclusive scientific consultant of Nextech Invest.